医学部附属病院

齊藤 景子

サイトウ ケイコ  (Keiko Saito)

基本情報

所属
千葉大学 医学部附属病院 特任助教
学位
医学博士(2014年3月 千葉大学)

J-GLOBAL ID
202201003896496794
researchmap会員ID
R000032237

主要な論文

 123
  • Keiko Saito, Tatsuro Katsuno, Tomoo Nakagawa, Shoko Minemura, Arata Oyamada, Naoya Kanogawa, Masaya Saito, Sayuri Yoshihama, Daisuke Maruoka, Tomoaki Matsumura, Makoto Arai, Takayuki Tohma, Hideaki Miyauchi, Hisahiro Matsubara, Osamu Yokosuka
    Internal medicine (Tokyo, Japan) 53(21) 2477-81 2014年  
    We encountered a rare case of severe diffuse duodenitis associated with ulcerative colitis (UC). A 23-year-old man underwent total proctocolectomy with ileal J-pouch anal anastomosis for UC. He suffered from severe abdominal pain, fever and bloody diarrhea for six months after the surgery. Upper double-balloon enteroscopy disclosed severe diffuse duodenitis, of which the findings were endoscopically and histologically similar to those of colonic lesions of UC. Although the administration of prednisolone was ineffective, treatment with intravenous tacrolimus markedly improved the clinical findings. This is the first report of the successful treatment of severe UC-associated diffuse duodenitis with intravenous tacrolimus.
  • K Saito, T Katsuno, T Nakagawa, M Saito, S Sazuka, T Sato, T Matsumura, M Arai, H Miyauchi, H Matsubara, O Yokosuka
    Alimentary pharmacology & therapeutics 36(8) 744-54 2012年10月  
    BACKGROUND: When treating patients with severe ulcerative colitis (UC), accurate prediction of drug efficacy contributes to early clinical decision-making. AIM: To identify predictive factors and to develop a reliable prediction formula and a decision tree of response to intravenous ciclosporin treatment for severe UC. METHODS: Patients included in this study were those diagnosed with refractory severe UC who had undergone ciclosporin treatment between December 2004 and March 2011 at a tertiary referral centre in Japan. Demographic and clinical parameters from all patients were analysed by multivariate statistics. RESULTS: Fifty-two patients were included in this study (36.5% men with an average age of ciclosporin initiation of 40.2 ± 15.6 years). Thirty-four patients (65.4%) were responders to the treatment with ciclosporin and avoided colectomy, 18 patients (34.6%) were nonresponders and underwent colectomy. Stepwise multiple logistic regression analysis identified four independent predictive factors of response to intravenous ciclosporin: age at hospitalisation (AGE), platelet count (×10(4) /μL) on the first day (PLA), Lichtiger score on the third day (LIC) and total protein (g/dL) on the third day minus total protein on the first day (ΔTP). The calculation formula (8.5 - 0.16 × AGE + 0.21 × PLA - 0.61 × LIC + 2.3 × ΔTP < 0) predicted colectomy with an accuracy of 88.5% and the decision tree predicted colectomy with an accuracy of 90.4%. CONCLUSION: The novel calculation formula and the decision tree effectively predict the clinical outcome of ciclosporin treatment for severe ulcerative colitis as early as on day 3 after starting ciclosporin treatment.

MISC

 72

共同研究・競争的資金等の研究課題

 1